MCID: CRB026
MIFTS: 35

Cerebellar Astrocytoma

Categories: Bone diseases, Cancer diseases, Neuronal diseases

Aliases & Classifications for Cerebellar Astrocytoma

MalaCards integrated aliases for Cerebellar Astrocytoma:

Name: Cerebellar Astrocytoma 12 15 71
Astrocytoma of Cerebellum 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4848
NCIt 49 C9475
UMLS 71 C0740480

Summaries for Cerebellar Astrocytoma

MalaCards based summary : Cerebellar Astrocytoma, also known as astrocytoma of cerebellum, is related to juvenile pilocytic astrocytoma and optic nerve glioma. An important gene associated with Cerebellar Astrocytoma is SERPINA3 (Serpin Family A Member 3), and among its related pathways/superpathways are Oncogenic MAPK signaling and G-protein signaling TC21 regulation pathway. The drugs Carboplatin and Temozolomide have been mentioned in the context of this disorder. Affiliated tissues include brain, cerebellum and bone.

Related Diseases for Cerebellar Astrocytoma

Diseases related to Cerebellar Astrocytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 169)
# Related Disease Score Top Affiliating Genes
1 juvenile pilocytic astrocytoma 30.3 NF1 KIAA1549 IDH1 H3-3B
2 optic nerve glioma 30.2 NF1 KIAA1549
3 astroblastoma 30.0 IDH1 BRAF
4 juvenile astrocytoma 29.6 KIAA1549 IDH1 FAM131B BRAF
5 grade iii astrocytoma 29.5 KIAA1549 IDH2 IDH1 H3-3B
6 glioma 29.4 NF1 IDH2 IDH1 BRAF
7 glioblastoma multiforme 28.7 NF1 IDH2 IDH1 H3-3B BRAF
8 fibrillary astrocytoma 28.7 NF1 KIAA1549 IDH2 IDH1 H3-3B FAM131B
9 pilocytic astrocytoma of cerebellum 26.6 RNF130 PASD1 MKRN1 KIAA1549 IDH1 H3-3B
10 cerebellar astrocytoma, childhood 12.3
11 childhood cerebellar astrocytic neoplasm 11.4
12 astrocytoma 10.9
13 hydrocephalus 10.4
14 cerebellar liponeurocytoma 10.4 KIAA1549 FAM131B
15 clear cell ependymoma 10.3 KIAA1549 IDH1
16 medulloblastoma 10.3
17 peripheral nerve schwannoma 10.3 SERPINA3 NF1
18 malignant spindle cell melanoma 10.3 SERPINA3 NF1
19 giant cell reparative granuloma 10.3 SERPINA3 NF1
20 gliofibroma 10.3 NF1 IDH1
21 elephantiasis 10.3 SERPINA3 NF1
22 syringocystadenoma papilliferum 10.3 SERPINA3 BRAF
23 persistent generalized lymphadenopathy 10.3 SERPINA3 NF1
24 pathologic nystagmus 10.2
25 juvenile xanthogranuloma 10.2 SERPINA3 BRAF
26 ossifying fibroma 10.2 SERPINA3 NF1
27 erdheim-chester disease 10.2 SERPINA3 BRAF
28 urachal adenocarcinoma 10.2 NF1 BRAF
29 dysembryoplastic neuroepithelial tumor 10.2 KIAA1549 IDH1 FAM131B
30 nervous system cancer 10.2 SERPINA3 NF1 IDH1
31 neurofibromatosis, type iv, of riccardi 10.1
32 optic nerve neoplasm 10.1 NF1 KIAA1549 FAM131B
33 subependymal glioma 10.1 NF1 KIAA1549 FAM131B
34 spinal cancer 10.1 NF1 KIAA1549 IDH1
35 enchondroma 10.1 IDH2 IDH1
36 breast duct papilloma 10.1 IDH2 IDH1
37 cytogenetically normal acute myeloid leukemia 10.1 IDH2 IDH1
38 intracranial chondrosarcoma 10.1 IDH2 IDH1
39 central nervous system rhabdomyosarcoma 10.1 IDH2 IDH1
40 periosteal chondrosarcoma 10.1 IDH2 IDH1
41 breast hemangioma 10.1 IDH2 IDH1
42 juxtacortical chondroma 10.1 IDH2 IDH1
43 interval angle-closure glaucoma 10.1 IDH2 IDH1
44 gemistocytic astrocytoma 10.1 IDH2 IDH1
45 ataxia and polyneuropathy, adult-onset 10.1
46 intracranial hypertension 10.1
47 glial tumor 10.1
48 undifferentiated pleomorphic sarcoma 10.1 IDH2 IDH1
49 papillary craniopharyngioma 10.1 KIAA1549 FAM131B BRAF
50 intraductal breast neoplasm 10.1 IDH2 IDH1

Graphical network of the top 20 diseases related to Cerebellar Astrocytoma:



Diseases related to Cerebellar Astrocytoma

Symptoms & Phenotypes for Cerebellar Astrocytoma

Drugs & Therapeutics for Cerebellar Astrocytoma

Drugs for Cerebellar Astrocytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 173)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Carboplatin Approved Phase 3 41575-94-4 10339178 498142 38904
2
Temozolomide Approved, Investigational Phase 3 85622-93-1 5394
3
Lenograstim Approved, Investigational Phase 3 135968-09-1
4
Methotrexate Approved Phase 3 1959-05-2, 59-05-2 126941
5
leucovorin Approved Phase 3 58-05-9 6006 143
6
Mechlorethamine Approved, Investigational Phase 3 51-75-2 4033
7
Prednisone Approved, Vet_approved Phase 3 53-03-2 5865
8
Levoleucovorin Approved, Investigational Phase 3 68538-85-2
9
Etoposide Approved Phase 3 33419-42-0 36462
10
Ifosfamide Approved Phase 3 3778-73-2 3690
11
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
12
Cisplatin Approved Phase 3 15663-27-1 84093 441203 2767
13
Ondansetron Approved Phase 3 99614-02-5 4595
14
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
15
Sargramostim Approved, Investigational Phase 3 123774-72-1, 83869-56-1
16
Procarbazine Approved, Investigational Phase 3 671-16-9 4915
17
Thioguanine Approved Phase 3 154-42-7 2723601
18
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
19
Lomustine Approved, Investigational Phase 3 13010-47-4 3950
20
Thiotepa Approved, Investigational Phase 3 52-24-4 5453
21
Isotretinoin Approved Phase 3 4759-48-2 5538 5282379
22
Histamine Approved, Investigational Phase 3 51-45-6 774
23
Cyproheptadine Approved Phase 3 129-03-3 2913
24
Folic acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
25
Calcium Approved, Nutraceutical Phase 3 7440-70-2 271
26
Tretinoin Approved, Investigational, Nutraceutical Phase 3 302-79-4 5538 444795
27 Immunologic Factors Phase 3
28 Alkylating Agents Phase 3
29 Topoisomerase Inhibitors Phase 3
30 Immunosuppressive Agents Phase 3
31 Folic Acid Antagonists Phase 3
32 Vitamin B Complex Phase 3
33 Folate Phase 3
34 Hormone Antagonists Phase 3
35 Vitamin B9 Phase 3
36 Calcium, Dietary Phase 3
37 Antirheumatic Agents Phase 3
38 Anti-Inflammatory Agents Phase 3
39 glucocorticoids Phase 3
40 Antineoplastic Agents, Hormonal Phase 3
41 Hormones Phase 3
42
Isophosphamide mustard Phase 3 0
43 Etoposide phosphate Phase 3
44 Autonomic Agents Phase 3
45 Emetics Phase 3
46 Antiemetics Phase 3
47 Antimitotic Agents Phase 3
48 Antimetabolites Phase 3
49 Adjuvants, Immunologic Phase 3
50 Gastrointestinal Agents Phase 3

Interventional clinical trials:

(show top 50) (show all 76)
# Name Status NCT ID Phase Drugs
1 Ultimate Low Grade Glioma Study Unknown status NCT00003015 Phase 3 carboplatin;vincristine sulfate
2 Treatment of Children and Adolescents With Diffuse Intrinsic Pontine Glioma and High Grade Glioma Unknown status NCT00278278 Phase 3 cisplatin;etoposide;ifosfamide;lomustine;methotrexate;prednisone;vincristine sulfate
3 Dose Intensive Chemotherapy for Children Less Than Ten Years of Age Newly-Diagnosed With Malignant Brain Tumors: A Pilot Study of Two Alternative Intensive Induction Chemotherapy Regimens, Followed by Consolidation With Myeloablative Chemotherapy (Thiotepa and Carboplatin, With or Without Etoposide) and Autologous Stem Cell Rescue [HEAD START III] Unknown status NCT00392886 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide;methotrexate;temozolomide;thiotepa;vincristine sulfate
4 Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy Completed NCT01346267 Phase 3
5 Chemotherapy for Progressive Low Grade Astrocytoma in Children Less Than Ten Years Old Completed NCT00002944 Phase 3 carboplatin;lomustine;procarbazine hydrochloride;thioguanine;vincristine sulfate
6 A Phase III Randomized Trial for the Treatment of Pediatric High Grade Gliomas at First Recurrence With a Single High Dose Chemotherapy and Autologous Stem Cell Transplant Versus Three Courses of Intermediate Dose Chemotherapy With Peripheral Blood Stem Cell (PBSC) Support Completed NCT00078988 Phase 3 carboplatin;etoposide;isotretinoin;thiotepa
7 Prevention of Cancer/Treatment-Related Weight Loss in Children at High Nutritional Risk Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
8 Pediatric Low Grade Astrocytoma: Treatment Guidance Unknown status NCT00005084 Phase 2
9 Phase II Study of the Combination of Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents at Diagnosis or in Relapse Unknown status NCT00360945 Phase 2 cisplatin;temozolomide
10 Continuous Infusion Thiotepa in High Grade Astrocytic Tumors of Childhood and Adolescence A UKCCSG Phase II Study Involving the Brain Tumour and New Agent Groups Unknown status NCT00313521 Phase 2 thiotepa
11 Management of Children Aged Less Than 3 Years With Brain Tumors Unknown status NCT00281905 Phase 2 carboplatin;cisplatin;cyclophosphamide;methotrexate;vincristine sulfate
12 PHASE II STUDY OF CARBOPLATIN (CBDCA) IN THE TREATMENT OF CHILDREN AND ADULTS WITH PROGRESSIVE LOW GRADE GLIOMAS Completed NCT00002749 Phase 2 carboplatin
13 A Phase II Study of Conformal Radiotherapy In Patients With Low-Grade Gliomas Completed NCT00238264 Phase 2
14 Treatment of Newly Diagnosed High-Grade Gliomas in Patients Ages Greater Than or Equal to 3 and Less Than or Equal to 21 Years With a Phase II Irinotecan Window Followed by Radiation Therapy and Temozolomide Completed NCT00004068 Phase 2 irinotecan hydrochloride;temozolomide
15 A Phase II Study of Navelbine (Vinorelbine) In Children With Recurrent Or Refractory Malignancies Completed NCT00003234 Phase 2 vinorelbine tartrate
16 A PHASE II STUDY OF DOCETAXEL (TAXOTERE) (NSC# 628503) IN CHILDREN WITH RECURRENT SOLID TUMORS Completed NCT00002825 Phase 2 docetaxel
17 Cilengitide (EMD 121974) (IND# 59073) in Recurrent or Progressive and Refractory Childhood High-Grade Glioma Completed NCT00679354 Phase 2 cilengitide
18 A Phase I/II Trial of Temodar in Pediatric Patients and Young Adults With High-Risk or Recurrent Solid Tumors Completed NCT00005952 Phase 1, Phase 2 temozolomide
19 Phase II Study of Methotrexate, Mechlorethamine, Vincristine, Prednisone, and Procarbazine (MMOPP) as Primary Therapy in Infants or Young Children With Primitive Neuroectodermal Tumors or High-Grade Astrocytoma Completed NCT00002463 Phase 2 MOPP Regimen;Leucovorin Calcium;Mechlorethamine Hydrochloride;Methotrexate;Prednisone;Procarbazine Hydrochloride;Vincristine Sulfate
20 Phase II Study of Phenylacetate in Pediatric Patients With Central Nervous System Tumors Completed NCT00003241 Phase 2 phenylacetate
21 PHASE I STUDY OF ANTI-TENASCIN MONOCLONAL ANTIBODY 131I 81C6 VIA SURGICALLY CREATED CYSTIC RESECTION CAVITY IN THE TREATMENT OF PATIENTS WITH PRIMARY OR METASTATIC MALIGNANT BRAIN TUMORS Completed NCT00002752 Phase 1, Phase 2
22 A Phase II Trial of Intravenous Cereport (RMP-7) and Carboplatin in Childhood Brain Tumors Completed NCT00019422 Phase 2 carboplatin;lobradimil
23 CAMP 013:- Tandem Thiotepa Regimen For Selected Malignant Gliomas:1) Primary Or Recurrent Glioblastoma Multiforme (GBM); and 2) Recurrent Anaplastic Astrocytomas (AA), Oligodendrogliomas (O), Oligoastrocytomas (OA), Ependymomas And Primitive Neuroectodermal Tumors (PNET) That Have Either Progressed After Primary Therapy Or Are Refractory To Standard Chemotherapy Completed NCT00008008 Phase 2 cyclophosphamide;thiotepa
24 A Phase II Trial of Rebeccamycin Analogue (NSC #655649) in Children With Solid Tumors Completed NCT00006102 Phase 2 becatecarin
25 Phase II Treatment of Children With Newly Diagnosed Malignant Central Nervous System Tumors With Temozolomide Prior to Radiation Therapy Completed NCT00005955 Phase 2 temozolomide
26 Cisplatin, Doxorubicin and Tamoxifen in the Treatment of Incurable Soft Tissue and Endocrine Malignancies Completed NCT00002608 Phase 2 cisplatin;doxorubicin hydrochloride;tamoxifen citrate
27 The Effect of Cyproheptadine Hydrochloride (Periactin) and Megestrol Acetate (Megace) on Weight in Children With Cancer/Treatment Related Cachexia Completed NCT00066248 Phase 2 cyproheptadine hydrochloride;megestrol acetate
28 A Phase I/II Trial of a New Tyrosine Kinase Inhibitor (Tarceva; Erlotinib Hydrochloride; OSI-774) During and After Radiotherapy in the Treatment of Patients With Newly Diagnosed High Grade Glioma and Unfavorable Low-Grade Glioma Completed NCT00124657 Phase 1, Phase 2 Erlotinib hydrochloride
29 Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms Active, not recruiting NCT00445965 Phase 2
30 Dasatinib With Ifosfamide, Carboplatin, Etoposide: A Pediatric Phase I/II Trial Active, not recruiting NCT00788125 Phase 1, Phase 2 carboplatin;dasatinib;etoposide phosphate;ifosfamide
31 Photodynamic Therapy For Childhood Brain Tumors, A Phase I Study Unknown status NCT00002647 Phase 1 verteporfin
32 Phase I Studies of TARCEVA™ (ERLOTINIB HYDROCHLORIDE, OSI-774) as Single Agent in Children With Refractory and Relapsed Malignant Brain Tumors and in Combination With Irradiation in Newly Diagnosed Brain Stem Glioma Unknown status NCT00360854 Phase 1 erlotinib hydrochloride
33 A Phase I Study Of Vaccination With Telomerase Peptide Plus GM-CSF Completed NCT00069940 Phase 1
34 Phase I Study of Doxorubicin HCl Liposome in Pediatric Patients With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
35 A Pilot Study of Dose-Intensified Procarbazine, CCNU, Vincristine (PCV) for Poor Prognosis Pediatric and Adult Brain Tumors Utilizing Fibronectin-Assisted, Retroviral-Mediated Modification of CD34+ Peripheral Blood Cells With O6-Methylguanine DNA Methyltransferase Completed NCT00005796 Phase 1 lomustine;procarbazine hydrochloride;vincristine sulfate
36 A Phase I Dose Escalation Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Pediatric Patients With Advanced Solid Tumors and Lymphomas Completed NCT00004212 Phase 1 exatecan mesylate
37 Phase I Trial Of Escalating Oral Doses Of SCH 66336 In Pediatric Patients With Refractory Or Recurrent Brain Tumors Completed NCT00015899 Phase 1 lonafarnib
38 High Dose Carboplatin Combined With Oral VP-16 In The Treatment Of Pediatric CNS Malignancies Completed NCT00053118 Phase 1 carboplatin;etoposide
39 Phase I Study Of Cloretazine (VNP40101M) In Children With Recurrent, Progressive Or Refractory Primary Brain Tumors Completed NCT00098761 Phase 1 laromustine
40 Phase I Study of Intrathecal Spartaject-Busulfan in Children With Neoplastic Meningitis Completed NCT00006246 Phase 1 busulfan
41 A Trial of 06-BG and BCNU in Children With CNS Tumors Completed NCT00003765 Phase 1 O6-benzylguanine;carmustine
42 A Phase I Study of Vinblastine in Combination With Carboplatin for Children With Newly Diagnosed and Recurrent Low-Grade Gliomas Completed NCT00352495 Phase 1 carboplatin;vinblastine sulfate
43 Phase I and Pharmacokinetic Trial of PTC299 in Pediatric Patients With Refractory or Recurrent CNS Tumors Completed NCT01158300 Phase 1 VEGF inhibitor PTC299
44 Phase I and Pharmacokinetic Study of Enzastaurin (LY317615) in Children and Adolescents With Refractory Primary CNS Tumors Completed NCT00503724 Phase 1 enzastaurin hydrochloride
45 A Phase I Study of Temozolomide, Oral Irinotecan, and Vincristine for Children With Refractory Solid Tumors Completed NCT00138216 Phase 1 irinotecan hydrochloride;temozolomide;vincristine sulfate
46 Phase I Trial and Pharmacokinetic Study of ABT-751, an Orally Bioavailable Tubulin Binding Agent, on a 7 Day and 21 Day Dosing Schedule in Pediatric Patients With Refractory Solid Tumors Completed NCT00036959 Phase 1 ABT-751
47 Phase I Trial and Pharmacokinetic Study of Temozolomide and O6-Benzylguanine in Childhood Solid Tumors Completed NCT00020150 Phase 1 O6-benzylguanine;temozolomide
48 A Phase I Study of Valproic Acid in Children With Recurrent/Progressive Solid Tumors Including CNS Tumors Completed NCT00107458 Phase 1 valproic acid
49 A Phase I Study of Thrombopoietin (rhTPO) Plus G-CSF in Children Receiving Ifosfamide, Carboplatin, and Etoposide (I.C.E.) Chemotherapy for Recurrent or Refractory Solid Tumors Completed NCT00003597 Phase 1 carboplatin;etoposide;ifosfamide
50 A Pilot Study of Intensive Chemotherapy With Peripheral Stem Cell Support for Infants With Malignant Brain Tumors Completed NCT00003141 Phase 1 carboplatin;cisplatin;cyclophosphamide;etoposide;thiotepa;vincristine sulfate

Search NIH Clinical Center for Cerebellar Astrocytoma

Genetic Tests for Cerebellar Astrocytoma

Anatomical Context for Cerebellar Astrocytoma

MalaCards organs/tissues related to Cerebellar Astrocytoma:

40
Brain, Cerebellum, Bone, Myeloid, Breast, Spinal Cord, Liver

Publications for Cerebellar Astrocytoma

Articles related to Cerebellar Astrocytoma:

(show top 50) (show all 254)
# Title Authors PMID Year
1
Peripheral retinal neovascularization in a patient with pilocytic astrocytoma. 61
31771349 2019
2
Medulloblastoma: Clinical presentation. 61
31494131 2019
3
"Cerebellar lesions after low-grade tumor resection can induce memory impairment in children, similar to that observed in patients with frontal lesions". 61
31451041 2019
4
Language Cerebro-cerebellar Reorganization in Children After Surgery of Right Cerebellar Astrocytoma: a fMRI Study. 61
31111430 2019
5
Treatment of corneal neovascularization with topical aflibercept in a case of exposure keratopathy following cerebellar astrocytoma surgery. 61
30574927 2019
6
Giant congenital melanocytic nevus associated with cerebellar astrocytoma. 61
29619995 2018
7
Improvement of visual field defects after focal resection for occipital lobe epilepsy: case report. 61
28524796 2018
8
The visuospatial functions in children after cerebellar low-grade astrocytoma surgery: A contribution to the pediatric neuropsychology of the cerebellum. 61
26638981 2017
9
Novel compound heterozygous mutations in a child with Ataxia-Telangiectasia showing unrelated cerebellar disorders. 61
27871447 2016
10
Post-operative accidental diagnosis of intra-cerebellar astrocytoma in an emergency appendicectomy case. 61
26962259 2016
11
Screening for cognitive deficits in 8 to 14-year old children with cerebellar tumors using self-report measures of executive and behavioral functioning and health-related quality of life. 61
26203065 2015
12
Pediatric cerebellar astrocytoma: a review. 61
26351221 2015
13
Intramedullary spinal glioblastoma metastasis from anaplastic astrocytoma of cerebellum: A case report and review of the literature. 61
26396627 2015
14
Spontaneous Malignant Transformation of a Pilocytic Astrocytoma of Cerebellum: Case Report. 61
28503586 2015
15
Long-term functional outcome of patients with cerebellar pilocytic astrocytoma surgically treated in childhood. 61
25383654 2015
16
Child-related characteristics predicting subsequent health-related quality of life in 8- to 14-year-old children with and without cerebellar tumors: a prospective longitudinal study. 61
26034623 2014
17
[Hyponatremia caused by SIADH following endoscopic third ventriculostomy: a case report]. 61
24698894 2014
18
Cerebellar astrocytoma presenting with headache and nystagmus in a 20-year-old male. 61
24485699 2014
19
Physical functioning in pediatric survivors of childhood posterior fossa brain tumors. 61
24305707 2014
20
The lost art of localization: Franc Ingraham's legacy in pediatric neurosurgery. 61
24073750 2013
21
Arrested growth and spontaneous tumor regression of partially resected low-grade cerebellar astrocytomas in children. 61
23632690 2013
22
Neurological morbidity of surgical resection of pediatric cerebellar astrocytomas. 61
23715810 2013
23
Neurosurgical treatment of low-grade cerebellar astrocytoma in children and adolescents: a single consecutive institutional series of 100 patients. 61
23240848 2013
24
Paediatric intra-axial posterior fossa tumours: pictorial review. 61
22977284 2013
25
Long-term follow-up of pediatric benign cerebellar astrocytomas. 61
21808215 2012
26
Spatial orientation deficit in children due to cerebellum astrocytoma pediatric tumor obtained by means of the Attentional Network Test. 61
21964389 2011
27
Long-term operative failure of endoscopic third ventriculostomy in pediatric patients: the role of cine phase-contrast MR imaging. 61
21456920 2011
28
Depressed skull fracture by a three-pin head holder: a case illustration. 61
20574740 2011
29
Posterior fossa tumors in children with neurofibromatosis type 1 (NF1). 61
20464401 2010
30
Calcified epidural hematoma in pediatric age group: A report of two cases. 61
21808510 2010
31
Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy. 61
19864079 2010
32
Postoperative surveillance magnetic resonance imaging for cerebellar astrocytoma. 61
19960748 2009
33
Simultaneous conus medullaris ependymoma and cerebellar astrocytoma in the same patient. 61
19537133 2009
34
Radiation-induced cavernous hemangiomas: case report and literature review. 61
19534329 2009
35
A case of an anaplastic ependymoma with gliosarcomatous components. 61
19408092 2009
36
Outcome of children with low-grade cerebellar astrocytoma: long-term complications and quality of life. 61
18690461 2008
37
[Elderly patient with cerebellar malignant astrocytoma]. 61
18800635 2008
38
Medial temporal lobe epilepsy associated with misplacement of a ventricular shunting catheter. 61
18502644 2008
39
Differential prefrontal-like deficit in children after cerebellar astrocytoma and medulloblastoma tumor. 61
18412947 2008
40
Report of a radiation-induced leiomyosarcoma arising from the posterior neck. 61
17912075 2007
41
Long-term neuromotor speech deficits in survivors of childhood posterior fossa tumors: effects of tumor type, radiation, age at diagnosis, and survival years. 61
17715277 2007
42
Cerebellar astrocytoma presenting with precocious puberty in a girl. Case report. 61
17644924 2007
43
Hemifacial spasm as the initial manifestation of childhood cerebellar astrocytoma. 61
17070492 2006
44
Epilepsy and neuropsychologic deficit in a child with cerebellar astrocytoma. 61
16970895 2006
45
Spontaneous regression of cerebellar astrocytoma after subtotal resection. 61
16552566 2006
46
Response to chemotherapy of a radiation-induced glioblastoma multiforme. 61
16314941 2006
47
Long-term effects of transient cerebellar mutism after cerebellar astrocytoma or medulloblastoma tumor resection in childhood. 61
16155765 2006
48
Children and adolescents with chronic cerebellar lesions show no clinically relevant signs of aphasia or neglect. 61
16033937 2005
49
Behavioral and affective changes in children and adolescents with chronic cerebellar lesions. 61
15882798 2005
50
Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood. 61
15886508 2005

Variations for Cerebellar Astrocytoma

Expression for Cerebellar Astrocytoma

Search GEO for disease gene expression data for Cerebellar Astrocytoma.

Pathways for Cerebellar Astrocytoma

Pathways related to Cerebellar Astrocytoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.15 NF1 KIAA1549 FAM131B CLCN6 BRAF
2
Show member pathways
10.89 NF1 BRAF
3
Show member pathways
10.07 IDH2 IDH1

GO Terms for Cerebellar Astrocytoma

Biological processes related to Cerebellar Astrocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 tricarboxylic acid cycle GO:0006099 9.32 IDH2 IDH1
2 2-oxoglutarate metabolic process GO:0006103 9.26 IDH2 IDH1
3 NADP metabolic process GO:0006739 9.16 IDH2 IDH1
4 isocitrate metabolic process GO:0006102 8.96 IDH2 IDH1
5 glyoxylate cycle GO:0006097 8.62 IDH2 IDH1

Molecular functions related to Cerebellar Astrocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor GO:0016616 9.16 IDH2 IDH1
2 isocitrate dehydrogenase (NADP+) activity GO:0004450 8.96 IDH2 IDH1
3 isocitrate dehydrogenase activity GO:0004448 8.62 IDH2 IDH1

Sources for Cerebellar Astrocytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....